Skip to main content

Channelopathies in Heart Disease

Introduction and Book Overview

  • Chapter
  • First Online:
Channelopathies in Heart Disease

Part of the book series: Cardiac and Vascular Biology ((Abbreviated title: Card. vasc. biol.,volume 6))

Abstract

The book “Channelopathies in Heart Disease” provides a translational overview of current state-of-the art research on ion channel (dys)function, cardiac channelopathies, and inherited arrhythmia syndromes. The latest insight on the structure and function of cardiac ion channels and the pro-arrhythmic consequences of their dysfunction is presented. Clinical and genetic characteristics of various inherited channelopathies and arrhythmia syndromes are discussed, in addition to new technologies available to this translational research field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Reference

  • Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhythmias. Circulation. 2005;112:2517–29.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carol Ann Remme .

Editor information

Editors and Affiliations

Ethics declarations

Sources of Funding

This work was funded by a Priority Medicines Rare Diseases and Orphan Drugs grant (PM-Rare, 113303006 to C.A.R.) from The Netherlands Organization for Health Research and Development (ZonMw) and an Innovational Research Incentives Scheme Vidi grant from ZonMw (grant no. 91714371 to C.A.R.), by the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D.T.), the German Heart Foundation/German Foundation of Heart Research (F/08/14 to D.T.), the Joachim Siebeneicher Foundation (to D.T.), and the Baden-Wuerttemberg Ministry of Science, Research and Art (Sonderlinie Medizin to D.T.).

Conflict of Interest

C.A.R. has previously received research grants from Gilead Sciences. D.T. reports receiving lecture fees/honoraria from Bayer Vital, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer Pharma, Sanofi-Aventis, St. Jude Medical, and ZOLL CMS and research grant support from Daiichi Sankyo. D.T. filed a patent application for the use of K2P potassium channels for altering cardiac electrophysiology.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Remme, C.A., Thomas, D. (2018). Channelopathies in Heart Disease. In: Thomas, D., Remme, C. (eds) Channelopathies in Heart Disease . Cardiac and Vascular Biology, vol 6. Springer, Cham. https://doi.org/10.1007/978-3-319-77812-9_1

Download citation

Publish with us

Policies and ethics